Skip Navigation



JAC Advance Access published online on January 16, 2004

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh059
© 2004 by The British Society for Antimicrobial Chemotherapy
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
53/2/379    most recent
dkh059v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schwarz, S.
Right arrow Articles by Watts, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwarz, S.
Right arrow Articles by Watts, J. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 The British Society for Antimicrobial Chemotherapy

Brief report

In vitro activities of spectinomycin and comparator agents against Pasteurella multocida and Mannheimia haemolytica from respiratory tract infections of cattle

Stefan Schwarz 1 *, Corinna Kehrenberg 1 , Sarah A. Salmon 2 , and Jeffrey L. Watts 3

1 Institut für Tierzucht der Bundesforschungsanstalt für Landwirtschaft (FAL), Höltystrasse 10, 31535 Neustadt-Mariensee, Germany;
2 US Biologicals Clinical Affairs, Pfizer Animal Health, Kalamazoo, MI 49001;
3 US Biologicals Development, Pfizer Animal Health, Kalamazoo, MI 49001, USA

* Corresponding author. E-mail: stefan.schwarz{at}fal.de.

Received 15 July 2003 ; revised 3 November 2003 ; accepted 6 November 2003

Abstract

Objectives: Prior to the renewal of spectinomycin licensing for veterinary uses in Germany, 154 Pasteurella multocida and 148 Mannheimia haemolytica strains from respiratory tract infections in cattle were investigated for their MICs of spectinomycin and other antimicrobial agents. The data obtained should serve as a baseline from which to judge the future development of resistance. Moreover, the in vitro activity of spectinomycin in comparison with other antimicrobials should be assessed.

Methods: MIC determination for all 302 strains was performed by the broth dilution method and evaluated according to NCCLS standards. MIC50 and MIC90 values were calculated. Strains resistant to spectinomycin were subjected to PCR assays for genes known to mediate spectinomycin resistance in Gram-negative and Gram-positive bacteria.

Results: With the exception of resistance to sulfamethoxazole in P. multocida and M. haemolytica, and resistance to ampicillin in M. haemolytica, an overall low level of resistance was detected. A total of 93.5% of the P. multocida and 98.6% of the M. haemolytica strains were susceptible to spectinomycin, with MIC90s of 32 mg/L. PCR analysis showed that none of the spectinomycin-resistant strains carried any of the aadA gene subtypes, nor the genes spc or aad(9).

Conclusions: Prior to the renewal of spectinomycin, only a small number of spectinomycin-resistant strains was detected among bovine P. multocida and M. haemolytica. The genes responsible for spectinomycin resistance in these strains seemed to be different from those so far known to occur in other Gram-negative and Gram-positive bacteria.

Keywords: antibiotic resistance, aminocyclitol antibiotics, MIC determination, PCR analysis
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
C. Kehrenberg and S. Schwarz
Mutations in 16S rRNA and Ribosomal Protein S5 Associated with High-Level Spectinomycin Resistance in Pasteurella multocida
Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2244 - 2246.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
C. Kehrenberg and S. Schwarz
Distribution of Florfenicol Resistance Genes fexA and cfr among Chloramphenicol-Resistant Staphylococcus Isolates.
Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1156 - 1163.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
C. Kehrenberg, B. Catry, F. Haesebrouck, A. de Kruif, and S. Schwarz
Novel Spectinomycin/Streptomycin Resistance Gene, aadA14, from Pasteurella multocida
Antimicrob. Agents Chemother., July 1, 2005; 49(7): 3046 - 3049.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
G. B. Michael, M. Cardoso, and S. Schwarz
Class 1 integron-associated gene cassettes in Salmonella enterica subsp. enterica serovar Agona isolated from pig carcasses in Brazil
J. Antimicrob. Chemother., May 1, 2005; 55(5): 776 - 779.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
B. Catry, K. Chiers, S. Schwarz, C. Kehrenberg, A. Decostere, and A. de Kruif
Fatal Peritonitis Caused by Pasteurella multocida Capsular Type F in Calves
J. Clin. Microbiol., March 1, 2005; 43(3): 1480 - 1483.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.